Evidence map›Paper›PMID 24052089›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2014

Radiation risk and protection of patients in clinical SPECT/CT.

Gunnar Brix, Elke A Nekolla, Markus Borowski, Dietmar Noßke

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05010733 (SPECT-CT Metabolic and Morphological Study of Two Types of Cemented Hip Stem Protheses in Primary Total Hip Arthroplasty Patients), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05010733 naunknown statusnot on this mapstarted 2022, after this paper: background citation

SPECT-CT Metabolic and Morphological Study of Two Types of Cemented Hip Stem Protheses in Primary Total Hip Arthroplasty Patients: A Randomized Controlled Clinical Trial (SPECT-PROTMA)

TypeinterventionalSponsorDaniel Rodriguez PerezRan2022 to 2024Enrolled16ConditionsArthropathy of HipArmsTotal hip arthroplasty using the Exeter V40 cemented femoral stem, Total hip arthroplasty using the Müller Straight Stem
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Calibration and prediction of results after failed injection in SPECT renal dynamic imaging.American journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Review
  4. Article
  5. Zeitschrift fur medizinische Physik · 2024
    Article
  6. Article
  7. Article
  8. [Molecular and cellular biochemistry · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. [A computer tomography assisted method for the automatic detection of region of interest in dynamic kidney images].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2017
    Article
  17. Article
  18. The EANM practice guidelines for bone scintigraphy.European journal of nuclear medicine and molecular imaging · 2016
    Article
  19. Article
  20. Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CIT.American journal of nuclear medicine and molecular imaging · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Gunnar BrixDepartment of Medical and Occupational Radiation Protection, Federal Office for Radiation Protection, Ingolstädter Landstraße 1, 85764, Oberschleissheim, Germany, gbrix@bfs.de.
Elke A Nekolla
Markus Borowski
Dietmar Noßke

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical studies have demonstrated that hybrid single photon emission computed tomography (SPECT)/CT for various diagnostic issues has an added value as compared to SPECT alone. However, the combined acquisition of functional and anatomical images can substantially increase radiation exposure to patients, in particular when using a hybrid system with diagnostic CT capabilities. It is, therefore, essential to carefully balance the diagnostic needs and radiation protection requirements. To this end, the evidence on health effects induced by ionizing radiation is outlined. In addition, the essential concepts for estimating radiation doses and lifetime attributable cancer risks associated with SPECT/CT examinations are presented taking into account both the new recommendations of the International Commission on Radiological Protection (ICRP) as well as the most recent radiation risk models. Representative values of effective dose and lifetime attributable risk are reported for ten frequently used SPECT radiopharmaceuticals and five fully diagnostic partial-body CT examinations. A diagnostic CT scan acquired as part of a combined SPECT/CT examination contributes considerably to, and for some applications even dominates, the total patient exposure. For the common SPECT and CT examinations considered in this study, the lifetime attributable risk of developing a radiation-related cancer is less than 0.27 %/0.37 % for men/women older than 16 years, respectively, and decreases markedly with increasing age at exposure. Since there is no clinical indication for a SPECT/CT examination unless an emission scan has been indicated, the issue on justification comes down to the question of whether it is necessary to additionally acquire a low-dose CT for attenuation correction and anatomical localization of tracer uptake or even a fully diagnostic CT. In any case, SPECT/CT studies have to be optimized, e.g. by adapting dose reduction measures from state-of-the-art CT practice, and exposure levels should not exceed the national diagnostic reference levels for standard situations.

Indexed as

Radiation DosageHumansMultimodal ImagingRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonTomography, X-Ray ComputedRadiopharmaceuticals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.